Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Gainer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|May 22, 2008
Trans-sodium crocetinate for treating hypoxia/ischemiaJohn L Gainer
Shock (Augusta, Ga.)|November 17, 2004
TSC for hemorrhagic shock: effects on cytokines and blood pressureAmanda K Stennett, John L Gainer
Biotechnology Progress|April 5, 2003
Asymmetric synthesis with immobilized yeast in organic solvents: equilibrium conversion and effect of reactant partitioning on whole cell biocatalysisThomas R Gervais, Giorgio Carta, John L Gainer
The Journal of Physical Chemistry. B|September 15, 2006
trans-Sodium crocetinate and diffusion enhancementAmanda K Stennett, Gail L Dempsey, John L Gainer
Shock (Augusta, Ga.)|December 5, 2002
Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapyLisa J Giassi, A Kennon Poynter, John L Gainer
Shock (Augusta, Ga.)|June 5, 2007
Trans-sodium crocetinate and hemorrhagic shockAmanda K Stennett, Robert J Murray, James W Roy, et al.
Journal of Neurosurgery|May 14, 2016
Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiformeJohn L Gainer, Jason P Sheehan, James M Larner, et al.
Journal of Neurosurgery|December 8, 2009
Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigationHiroaki Manabe, David O Okonkwo, John L Gainer, et al.
Vascular Medicine (London, England)|October 18, 2011
Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudicationEmile R Mohler, John L Gainer, Kim Whitten, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|May 22, 2008
Trans-sodium crocetinate for treating hypoxia/ischemiaJohn L Gainer
Shock (Augusta, Ga.)|November 17, 2004
TSC for hemorrhagic shock: effects on cytokines and blood pressureAmanda K Stennett, John L Gainer
Biotechnology Progress|April 5, 2003
Asymmetric synthesis with immobilized yeast in organic solvents: equilibrium conversion and effect of reactant partitioning on whole cell biocatalysisThomas R Gervais, Giorgio Carta, John L Gainer
The Journal of Physical Chemistry. B|September 15, 2006
trans-Sodium crocetinate and diffusion enhancementAmanda K Stennett, Gail L Dempsey, John L Gainer
Shock (Augusta, Ga.)|December 5, 2002
Trans sodium crocetinate for hemorrhagic shock: effect of time delay in initiating therapyLisa J Giassi, A Kennon Poynter, John L Gainer
Shock (Augusta, Ga.)|June 5, 2007
Trans-sodium crocetinate and hemorrhagic shockAmanda K Stennett, Robert J Murray, James W Roy, et al.
Journal of Neurosurgery|May 14, 2016
Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiformeJohn L Gainer, Jason P Sheehan, James M Larner, et al.
Journal of Neurosurgery|December 8, 2009
Protection against focal ischemic injury to the brain by trans-sodium crocetinate. Laboratory investigationHiroaki Manabe, David O Okonkwo, John L Gainer, et al.
Vascular Medicine (London, England)|October 18, 2011
Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudicationEmile R Mohler, John L Gainer, Kim Whitten, et al.
Pageof 1